| 000 | 01159 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515063122.0 | ||
| 264 | 0 | _c20070817 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1472-4472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBates, Matthew G D | |
| 245 | 0 | 0 |
_aPhosphodiesterase type 5 inhibitors in the treatment and prevention of high altitude pulmonary edema. _h[electronic resource] |
| 260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cMar 2007 |
||
| 300 |
_a226-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_a3',5'-Cyclic-GMP Phosphodiesterases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAltitude Sickness _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 5 |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPulmonary Edema _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aThompson, A A Roger | |
| 700 | 1 | _aBaillie, J Kenneth | |
| 773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 8 _gno. 3 _gp. 226-31 |
|
| 999 |
_c16960246 _d16960246 |
||